Bendamustine Hydrochloride

CAS 3543-75-7 18 current records 4 historicalSmall Molecule

Who holds supplier records for Bendamustine Hydrochloride? 18 organisations hold a current record for Bendamustine Hydrochloride: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (9), United States (2), Germany (2), Italy (2) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Bendamustine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/bendamustine-hydrochloride

Reading the evidence

  • 18 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (18)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Bendamustine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Bendamustine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (4)

Organisations whose Type II DMFs for Bendamustine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 4 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Bendamustine Hydrochloride is a bifunctional alkylating agent used for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin's lymphoma (NHL). It interferes with the growth of cancer cells by causing DNA cross-linking, leading to cell death.

Chemical identity

IUPAC name
4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydrochloride
Canonical SMILES
CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl
InChIKey
ZHSKUOZOLHMKEA-UHFFFAOYSA-N
Synonyms
Treanda API, bendamustine hcl, bendeka, nsc-138783, ribomustin, ribomustine, sdx-105, syb l-0501, sybl-0501, treanda, vivimusta

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Alkylating Drug
Mechanism of action
Alkylating Activity

Therapeutic areas

Oncology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Bendamustine Hydrochloride?

18 organisations hold an active US FDA Type II Drug Master File or a CEP for Bendamustine Hydrochloride: BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD (China), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CHEMPACIFIC CORP (United States), CHONGQING HUAPONT PHARMACEUTICAL CO LTD, Dr. Reddy's Laboratories Ltd. (India), Emcure Pharmaceuticals Limited (India), FUXIN LONG RUI PHARMACEUTICAL CO LTD and HERAEUS PRECIOUS METALS GMBH AND CO KG (Germany), and 10 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Bendamustine Hydrochloride Drug Master Files are active?

BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD (DMF 28501), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 27483), CHEMPACIFIC CORP (DMF 22626), CHONGQING HUAPONT PHARMACEUTICAL CO LTD (DMF 25524), Dr. Reddy's Laboratories Ltd. (DMF 24823), Emcure Pharmaceuticals Limited (DMF 25807), FUXIN LONG RUI PHARMACEUTICAL CO LTD (DMF 33380) and HERAEUS PRECIOUS METALS GMBH AND CO KG (DMF 25512) and 10 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Bendamustine Hydrochloride records mean?

4 organisations have only inactive Type II DMFs for Bendamustine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Bendamustine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Bendamustine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.